|
BUSINESS WEEK author Barret suggests that medical research and in particular pharmaceutical studies are flawed. (Barrett, 2004:68-70) Numerous studies are financed by the same parties that want to sell a drug. Thus there is a conflict of interest. Nearly 60% of the studies are funded by “Big Pharma.” Researchers redefine data to show positive results, sample until a significant difference is found and then stop, down play negative results or delay these findings. Further, the drug companies hire ghost writers to write glowing reviews. Hire prominent medical doctors to endorse the drug. Spin the data, collapse spurious findings into significant ones, use non-random samples, and buy off regulatory bodies. Barrett (2005) also criticizes drug companies relative to their advertising. Healy(2005:8/8) is critical of pharmaceutical research on a natural
cold medicine that has 350 studies from Europe and the UK that suggest
that the herb is a viable support to pathological symptoms relative
to sinusitis and related. NEWSWEEK (2004) spends nearly the entire
issue on how alternative medicine can compliment western medicine.
Best selling author Gary Trudeau (without medical background) documents
others’ reports of fraud in the pharmaceutical industry (Trudeau,
2005) Mundy (2001) traces the story of how drug companies cover up
problems with a diet drug using fraud and deception. Ioannidis (2005:218-228)
in JAMA suggests that the most famous and well read studies do not
show the same degree of significant differences in follow up studies
and suggest the etiology of this problem. He further discusses numerous
research strategies that will generally render false or spurious findings
in NEW SCIENTIST DISCUSSION The authors would like to hypothetically indicate general strategies
that would SUGGEST that findings vary in the value of validity. Thus,
the reader can clearly identify the following: CRITERIA SPURIOUS FINDINGS: They are:
|